Previous 10 | Next 10 |
-- MIRROR open-label trial demonstrates 79 percent of patients achieved a complete response using KRYSTEXXA with methotrexate -- -- Additional data presentations highlight the effect of co-therapy for KRYSTEXXA with two other commonly used immunomodulators, supporting flexible options ...
This article is part of a series that provides an ongoing analysis of the changes made to John Paulson’s 13F stock portfolio on a quarterly basis. It is based on Paulson’s regulatory 13F Form filed on 05/15/2020. Please visit our Tracking John Paulson’s Paulson & Co...
Horizon Therapeutics plc (NASDAQ: HZNP) today announced that it has been named No. 1 on the Great Place to Work® “ Best Workplaces in Chicago 2020 ” list in the small and medium category. The list includes 39 other top small-to-medium sized companies, as well as 40 best lar...
-- Additional data presented will highlight the effect of urate deposition and link between gout and serious comorbidities -- -- Two oral presentations will be given on Thursday, June 4, 2020 -- Horizon Therapeutics plc (Nasdaq: HZNP) announced today that multiple case series and ...
Buffett is larger than life. An entire generation has now grown up with investing basics they've learned from random Buffett memes and gifs on Twitter. It's important: first, to listen to Buffett himself vs. what others say/quote about him; and second, to learn from his actions more than words...
Horizon Therapeutics (Nasdaq: HZNP) today announced that the Company will participate in the following upcoming conferences: Jefferies 2020 Virtual Healthcare Conference Date: Tuesday, June 2 BMO 2020 Prescriptions for Success Healthcare Conference (Virtual) Date...
-- Additional Horizon data accepted as a poster presentation at ENDO 2020 summarize the first U.S.-based assessment of the GO-QOL questionnaire and demonstrate the significant burden of Thyroid Eye Disease on patient quality of life -- Horizon Therapeutics plc (Nasdaq: HZNP) today ann...
-- In an analysis accepted for presentation at the American Association of Clinical Endocrinologists (AACE) Annual Scientific & Clinical Congress, physicians cite psychological well-being and ability to function in social situations as most impacted by the disease -- Horizon Therap...
Image source: The Motley Fool. Horizon Therapeutics PLC (NASDAQ: HZNP) Q1 2020 Earnings Call May 6, 2020 , 8:00 a.m. ET Operator Continue reading
Horizon Therapeutics Public Limited Company (HZNP) Q1 2020 Earnings Conference Call May 06, 2020 08:00 AM ET Company Participants Tina Ventura - Senior Vice President, Investor Relations Tim Walbert - Chairman, President & Chief Executive Officer Liz Thompson - Group Vice Pre...
News, Short Squeeze, Breakout and More Instantly...
Horizon Therapeutics Public Limited Company Company Name:
HZNP Stock Symbol:
NASDAQ Market:
Horizon Therapeutics Public Limited Company Website:
Hitachi Construction Machinery Co. Ltd ADR (HTCMY) is expected to report for Q2 2024 DigitalBridge Group Inc. (DBRG) is expected to report $0 for Q3 2023 LY Corp ADR (YAHOY) is expected to report for Q2 2024 DT Midstream Inc. (DTM) is expected to report $0.9 for Q3 2023 Summit Mat...
Horizon Therapeutics Public Limited Company (HZNP) is expected to report $1.22 for Q3 2023
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION FOR IMMEDIATE RELEASE October 6, 2023 RECOM...